Understanding Obesity Medications and Microdosing

This chapter examines the effectiveness of various obesity medications and their historical context, particularly focusing on microdosing practices in medicine. It discusses the rigorous drug testing processes and the challenges related to different dosing strategies, including patient experiences with medications like semaglutide. Additionally, the chapter highlights ethical concerns in the pharmaceutical industry and the implications of FDA decisions on drug accessibility and innovation.